Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease Geneva, 14 November 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in children and adolescents’ released today, and urged all countries with high TB burdens to prioritise … Read more
Jawahira was referred to the Médecins Sans Frontières (MSF) tuberculosis (TB) hospital in Kandahar earlier this year from a clinic in Daikundi, central Afghanistan. “I used to visit private clinics, but instead of giving me TB medication, they usually just prescribed me painkillers,” she says. The cost of searching out treatment also took its toll. … Read more
GENEVA/NEW YORK – Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the approval by the US Food and Drug Administration (FDA) of a combination regimen containing a new drug, pretomanid, for the treatment of extensively drug-resistant tuberculosis (XDR-TB). As the third new drug developed for TB in over half a century, and the first to be … Read more
Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to nearly all drugs available. But access to these new life-saving drugs in India remains greatly … Read more
Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available. Nischaya, eighteen years old, receives the … Read more